Showing results (221-230 of 289) with videos related to
Sort By:
Pageof 29
British Journal of Cancer|October 18, 2007
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patientsM Frattini, P Saletti, E Romagnani, et al.Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82H J Senn, R Maibach, M Castiglione, et al.Cancer Chemotherapy and Pharmacology|July 19, 2001
Phase I-II study of escalating doses of amifostine combined with high-dose cyclophosphamideM Ghielmini, S Van der Bosch, M Bosshard, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivativeO Pagani, M Zucchetti, C Sessa, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.Cancer|June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment centerR A Joss, K Bürki, P Dalquen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphomaD C Betticher, E Zucca, A von Rohr, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Phase I clinical and pharmacokinetic study of oral etoposide phosphateC Sessa, M Zucchetti, T Cerny, et al.Pageof 29